𝔖 Bobbio Scriptorium

✦ LIBER ✦

ChemInform Abstract: The Discovery of N-Cyclopropyl-4-methyl-3- [6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703, a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases.

✍ Scribed by John G. Cumming; et al. et al.

Book ID: 115553961
Publisher: John Wiley and Sons
Year: 2012
Weight: 45 KB
Volume: 43
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.201243208

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The discovery of N-cyclopropyl-4-methyl-

The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases

✍ Dearg S. Brown; John G. Cumming; Paul Bethel; Jonathan Finlayson; Stefan Gerhard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 864 KB

ChemInform Abstract: Discovery of N-[2-[

ChemInform Abstract: Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro-6- [3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl] -N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa.

✍ M. M. MORRISSEY; ET AL. ET AL. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

Correction to Discovery of a Novel Class

Correction to Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1 H -[1,2,3]triazolo[4,5- b ]pyrazin-6-yl)-1 H -pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer

✍ Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dubé, Michelle; Pairish, M 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 124 KB

ChemInform Abstract: Discovery of 5-(2-A

ChemInform Abstract: Discovery of 5-(2-Amino-[1,2,4]triazolo [1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a Potent, Orally Bioavailable and Selective Inhibitor of PI3K for the Treatment of Inflammatory Disease.

✍ Sunose, Mihiro; Bell, Kathryn; Ellard, Katie; Bergamini, Giovanna; Neubauer, Git 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 23 KB